Pfizer to rake in record-breaking earnings of over $100 billion in Covid vaccine and antiviral pill : The Tribune India

Join Whatsapp Channel

Pfizer to rake in record-breaking earnings of over $100 billion in Covid vaccine and antiviral pill

Company revealed its fourth quarter earnings and revenue projections for 2022

Pfizer to rake in record-breaking earnings of over $100 billion in Covid vaccine and antiviral pill

Vials with a sticker reading, ‘Covid-19 / Coronavirus vaccine / Injection only’ and a medical syringe are seen in front of a displayed Pfizer logo in this illustration. Reuters file photo



New Delhi, February 9

Pfizer estimates that it will rake in record-breaking earnings of more than $100 billion this year due to sales of its Covid-19 vaccine and antiviral pill to treat the virus, Daily Mail reported.

The rollout of the vaccine has already led to a substantial financial windfall for the New York City-based company, and the prospect on enhanced distribution of Paxlovid, the potential rollout of Omicron-tailored vaccines and more booster shots in the future will lead to an influx of even more cash.

On Tuesday, the company revealed its fourth quarter earnings and revenue projections for 2022 where it said it estimates it will earn up to $102 billion in sales next year, which would be a new record.

More than half of those earnings will be of its two Covid products, with the vaccine expected to bring in $32 billion in sales, and Paxlovid expected to earn $22 billion.

But despite the record earnings estimates, the drug maker posted mixed fourth-quarter results when it comes to actual revenue, with shares down 5.4 per cent in early morning trading. Shares were down 2.84 per cent by closing, the report said.

The Pfizer Covid-19 vaccine is the most commonly used jab in the US and many other countries around the world.

According to official data from the US Centers for Disease Control and Prevention (CDC), the jab has been used 319 million times - more than half of the 540 million vaccines administered in the nation overall.

This includes the nearly 50 million Pfizer booster shots that have been administered to Americans.

The company doubled its Q4 sales this year when compared to last, to $23.84 billion over the last three months of last year, the report said.

More than half of that revenue, $12.5 billion, came from the Covid vaccines alone.

This revenue stream will remain intact for years to come, potentially even the next decade, if Pfizer has its way.

IANS

#Covid #Pfizer


Top News

Results in 4 states on Dec 3 as BJP, Congress face crucial electoral test ahead of General Election

Results in 4 states on Dec 3 as BJP, Congress face crucial electoral test ahead of General Election

Counting of votes to commence at 8 am amid tight security

COP28: India, China refrain from signing pledge to triple world’s renewable energy capacity by 2030

COP28: India, China refrain from signing pledge to triple world's renewable energy capacity by 2030

The pledge calls for phase down of unabated coal power and p...

Magnitude 7.5 earthquake strikes Mindanao, Philippines

7.5-magnitude earthquake strikes Philippines' Mindanao; tsunami expected in Philippines and Japan

Tsunami waves could hit the Philippines by midnight local ti...

Winter session of Parliament set to be stormy, Ethics Committee to table report on TMC MP Mahua Moitra

Winter session of Parliament set to be stormy, Ethics Committee to table report on TMC MP Mahua Moitra

At all-party meeting, TMC leaders demand discussion in Lok S...

3 Khalistan supporters in New Zealand sentenced for plot to kill Kiwi radio host Harnek Singh

3 Khalistan supporters in New Zealand sentenced for plot to kill Kiwi radio host Harnek Singh

Sarvjeet Sidhu, pleaded guilty to attempted murder, while Su...


Cities

View All